U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C2H5O.Na
Molecular Weight 68.0503
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Sodium ethanolate

SMILES

[Na+].CC[O-]

InChI

InChIKey=QDRKDTQENPPHOJ-UHFFFAOYSA-N
InChI=1S/C2H5O.Na/c1-2-3;/h2H2,1H3;/q-1;+1

HIDE SMILES / InChI

Molecular Formula C2H5O
Molecular Weight 45.0605
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021074Orig1s010lbl.pdf https://www.ncbi.nlm.nih.gov/pubmed/17591544

Alcohols exhibit rapid broad-spectrum antimicrobial activity against vegetative bacteria (including mycobacteria), viruses, and fungi but are not sporicidal. They are, however, known to inhibit sporulation and spore germination, but this effect is reversible. Because of the lack of sporicidal activity, alcohols are not recommended for sterilization but are widely used for both hard-surface disinfection and skin antisepsis. Lower concentrations may also be used as preservatives and to potentiate the activity of other biocides. Many alcohol products include low levels of other biocides (in particular chlorhexidine), which remain on the skin following evaporation of the alcohol, or excipients (including emollients), which decrease the evaporation time of the alcohol and can significantly increase product efficacy. Ethanol in combination with: chlorhexidine gluconate 1% was approved to use in surgical hand antiseptic. It significantly reduces the number of microorganisms on the hands and forearms prior to surgery or patient care. Ethanol is also used as a co-solvent to dissolve many insoluble drugs and to serve as a mild sedative in some medicinal formulations. Ethanol is metabolized by the hepatic enzyme alcohol dehydrogenase. Ethanol affects the brain’s neurons in several ways. It alters their membranes as well as their ion channels, enzymes, and receptors. Alcohol also binds directly to the receptors for acetylcholine, serotonin, GABA, and the NMDA receptors for glutamate. The sedative effects of ethanol are mediated through binding to GABA receptors and glycine receptors (alpha 1 and alpha 2 subunits). It also inhibits NMDA receptor functioning. In its role as an anti-infective, ethanol acts as an osmolyte or dehydrating agent that disrupts the osmotic balance across cell membranes.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
AVAGARD

Approved Use

Surgical hand antiseptic: Significantly reduces the number of micro-organisms on the hands and forearms prior to surgery or patient care

Launch Date

2001
PubMed

PubMed

TitleDatePubMed
Increased production of human proinsulin in the periplasmic space of Escherichia coli by fusion to DsbA.
2001-11-30
Switching osmolyte strategies: response of Methanococcus thermolithotrophicus to changes in external NaCl.
2001-11-15
On the enzymatic activation of NADH.
2001-03-23
Regulation of the aldehyde dehydrogenase gene (aldA) and its role in the control of the coinducer level necessary for induction of the ethanol utilization pathway in Aspergillus nidulans.
2001-03-09
Phosphatidic acid regulates tyrosine phosphorylating activity in human neutrophils: enhancement of Fgr activity.
2001-02-16
Intracellular fluxes in a recombinant xylose-utilizing Saccharomyces cerevisiae cultivated anaerobically at different dilution rates and feed concentrations.
2001-02-05
Prediction of Fenton oxidation positions in polycyclic aromatic hydrocarbons by Frontier electron density.
2001-02
Bacterial release of arsenic ions and organoarsenic compounds from soil contaminated by chemical warfare agents.
2001-02
Microparticles of soy lecithin formed by supercritical processes.
2001-01-20
Energetics of growth and penicillin production in a high-producing strain of Penicillium chrysogenum.
2001-01-20
Efficient regression calibration for logistic regression in main study/internal validation study designs with an imperfect reference instrument.
2001-01-15
Expression of a cytoplasmic transhydrogenase in Saccharomyces cerevisiae results in formation of 2-oxoglutarate due to depletion of the NADPH pool.
2001-01-15
Morphometric assessment of testicular changes in drug-related fatalities.
2001-01-15
Caffeine dissociates complexes between DNA and intercalating dyes: application for bleaching fluorochrome-stained cells for their subsequent restaining and analysis by laser scanning cytometry.
2001-01-01
Biochemical characterization and mechanism of action of a thermostable beta-glucosidase purified from Thermoascus aurantiacus.
2001-01-01
Patients admitted to emergency services for drunkenness: moderate alcohol users or harmful drinkers?
2001-01
The efficacy of esmolol versus lidocaine to attenuate the hemodynamic response to intubation in isolated head trauma patients.
2001-01
Selected in-treatment outcomes of long-term methadone maintenance treatment patients in New York State.
2001-01
Integrating the methadone patient in the traditional addiction inpatient rehabilitation program--problems and solutions.
2001-01
Severe ethylene glycol ingestion treated without hemodialysis.
2001-01
Fomepizole in the treatment of poisoning.
2001-01
Major changes in human ocular UV protection with age.
2001-01
Inhibition of CYP2E1 with natural agents may be a feasible strategy for minimizing the hepatotoxicity of ethanol.
2001-01
Up-regulation of hepatic IGFBP-1 production as a strategy for preventing benign prostatic hyperplasia.
2001-01
Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo.
2001-01
Ethanol acts synergistically with a D2 dopamine agonist to cause translocation of protein kinase C.
2001-01
Outcome of hospital care of liver disease associated with hepatitis C in the United States.
2001-01
Uteroplacental insufficiency alters hepatic fatty acid-metabolizing enzymes in juvenile and adult rats.
2001-01
A single bout of exercise induces beta-adrenergic desensitization in human adipose tissue.
2001-01
Effects of posttraining ethanol on an appetitive task.
2001-01
Genetic alterations in head and neck cancer: interactions among environmental carcinogens, cell cycle control, and host DNA repair.
2001-01
DNA supercoiling-dependent transcriptional coupling between the divergently transcribed promoters of the ilvYC operon of Escherichia coli is proportional to promoter strengths and transcript lengths.
2001-01
Induction of ppGpp synthesis in Streptomyces coelicolor A3(2) grown under conditions of nutritional sufficiency elicits actII-ORF4 transcription and actinorhodin biosynthesis.
2001-01
Acute effects of 3,4-methylenedioxymethamphetamine alone and in combination with ethanol on the immune system in humans.
2001-01
Ethanol potentiation of glycine-induced responses in dissociated neurons of rat ventral tegmental area.
2001-01
Evaluation of surgical excision of non-homogeneous oral leukoplakia in a screening intervention trial, Kerala, India.
2001-01
Smoking and alcohol in the etiology of oral cancer: gender-specific risk profiles in the south of Greece.
2001-01
Mortality among women and men relative to unemployment, part time work, overtime work, and extra work: a study based on data from the Swedish twin registry.
2001-01
Evaluation of a modified German version of the Q16 questionnaire for neurotoxic symptoms in workers exposed to solvents.
2001-01
Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury.
2001-01
Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group.
2001-01
Glycosaminoglycan synthesis and secretion by the retinal pigment epithelium: polarized delivery of hyaluronan from the apical surface.
2001-01
Optimizing the sterilization of PLGA scaffolds for use in tissue engineering.
2001-01
Effect of short-term ethanol administration on cadmium excretion in rats.
2001-01
Preparation and characterization of chitin beads as a wound dressing precursor.
2001-01
Risk factors for pancreatic cancer: a case-control study based on direct interviews.
2001
Generalisation of ethanol with drug mixtures containing a positive modulator of the GABA(A) receptor and an NMDA antagonist.
2001
Laryngeal carcinoma--epidemiological and clinical features: experience of the Rabin Medical Center in Israel.
2000-12-15
Occupational health services for municipal employees.
2000-12-07
Acute ethanol decreases NPY mRNA but not POMC mRNA in the arcuate nucleus.
2000-11-09
Patents

Sample Use Guides

apply to clean, dry hands and nails
Route of Administration: Topical
Primary cultures of cortical neurons obtained from 1-day-old rats were exposed to EtOH after 7days of culture, and viability and morphology were analyzed at structural and ultrastructural levels after 24-h EtOH exposure. EtOH caused a significant reduction of 73±7% in the viability of cultured cortical neurons, by preferentially inducing apoptotic cellular death. This effect was accompanied by an increase in caspase 3 and 9 expression. EtOH induced a reduction in total dendrite length and in the number of dendrites per cell. Ultrastructural studies showed that EtOH increased the number of lipidic vacuoles, lysosomes and multilamellar vesicles and induced a dilated endoplasmatic reticulum lumen and a disorganized Golgi apparatus with a ring-shape appearance. Microtubules showed a disorganized distribution
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:11:56 GMT 2025
Edited
by admin
on Mon Mar 31 19:11:56 GMT 2025
Record UNII
1I9504387J
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SODIUM ETHANOLATE [HSDB]
Preferred Name English
Sodium ethanolate
HSDB  
Systematic Name English
SODIUM ETHOXIDE [MI]
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID3027089
Created by admin on Mon Mar 31 19:11:56 GMT 2025 , Edited by admin on Mon Mar 31 19:11:56 GMT 2025
PRIMARY
FDA UNII
1I9504387J
Created by admin on Mon Mar 31 19:11:56 GMT 2025 , Edited by admin on Mon Mar 31 19:11:56 GMT 2025
PRIMARY
WIKIPEDIA
Sodium ethoxide
Created by admin on Mon Mar 31 19:11:56 GMT 2025 , Edited by admin on Mon Mar 31 19:11:56 GMT 2025
PRIMARY
PUBCHEM
2723922
Created by admin on Mon Mar 31 19:11:56 GMT 2025 , Edited by admin on Mon Mar 31 19:11:56 GMT 2025
PRIMARY
CAS
141-52-6
Created by admin on Mon Mar 31 19:11:56 GMT 2025 , Edited by admin on Mon Mar 31 19:11:56 GMT 2025
PRIMARY
ECHA (EC/EINECS)
205-487-5
Created by admin on Mon Mar 31 19:11:56 GMT 2025 , Edited by admin on Mon Mar 31 19:11:56 GMT 2025
PRIMARY
CHEBI
52096
Created by admin on Mon Mar 31 19:11:56 GMT 2025 , Edited by admin on Mon Mar 31 19:11:56 GMT 2025
PRIMARY
HSDB
5637
Created by admin on Mon Mar 31 19:11:56 GMT 2025 , Edited by admin on Mon Mar 31 19:11:56 GMT 2025
PRIMARY
MERCK INDEX
m10019
Created by admin on Mon Mar 31 19:11:56 GMT 2025 , Edited by admin on Mon Mar 31 19:11:56 GMT 2025
PRIMARY Merck Index
Related Record Type Details
PARENT -> SALT/SOLVATE